Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 72789-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 72789-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789049 Label (72789049)

FDA Label Image

Figure 1 (Oxybutynin Fig 1)

Figure 1 (Oxybutynin Fig 1)
This is a chart comparing two dosages of a medication called OxybutyninER. One dosage is 10mg taken once a day (QD), while the other is 5mg taken three times a day (TID). The chart includes a time axis in hours but doesn't specify what is being measured over time.*
FDA Label Image

Figure 2 (Oxybutynin Fig 2)

FDA Label Image

Figure 3 (Oxybutynin Fig Study 1)

FDA Label Image

Figure 4 (Oxybutynin Fig Study 2)

FDA Label Image

Figure 5 (Oxybutynin Fig Study 3)

FDA Label Image

Chemical Structure (Oxybutynin Struc)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.